Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
topic_facet:"Protein Kinase Inhibitors"
topic_facet:"Randomized Controlled Trial"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22&filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Liu%2C+Geoffrey%22&type0%5B%5D=Person&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22&filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Liu%2C+Geoffrey%22&type0%5B%5D=Person&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Protein+Kinase+Inhibitors%22&filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Liu%2C+Geoffrey%22&type0%5B%5D=Person&op0%5B%5D=OR
PubPharm (5)
1
Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib : Results of Phase 3 ALTA-3 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2023
von
Yang, J.
|
Liu, G.
|
Lu, S.
| +11
Wird geladen...
2
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer : updated analysis of data from the phase 3, randomised, open-label CROWN study
enthalten in:
The Lancet. Respiratory medicine
| 2023
von
Solomon, B.
|
Bauer, T.
|
Mok, T.
| +15
CommentIn: Lancet Respir Med. 2023 Apr;11(4):302-304. - PMID 36535299
Wird geladen...
3
Patient-reported outcomes from the randomized phase 3 CROWN study of first-line lorlatinib versus crizotinib in advanced ALK-positive non-small cell lung cancer
enthalten in:
Lung cancer (Amsterdam, Netherlands)
| 2022
von
Mazieres, J.
|
Iadeluca, L.
|
Shaw, A.
| +11
Wird geladen...
4
Post Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK-Positive Advanced Non-Small-Cell Lung Cancer From the Phase III CROWN Study
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Solomon, B.
|
Bauer, T.
|
Ignatius Ou, S.
| +12
CommentIn: J Clin Oncol. 2022 Nov 1;40(31):3564-3568. - PMID 35679525
Wird geladen...
5
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26) : a double-blind, randomised, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2014
von
Ellis, P.
|
Shepherd, F.
|
Millward, M.
| +24
CommentIn: Lancet Oncol. 2014 Nov;15(12):1289-90. - PMID 25439684
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Protein Kinase Inhibitors
Filter aufheben
Thema: Randomized Controlled Trial
Medienart
5
Aufsätze
5
E-Artikel
5
E-Ressourcen
Zeitschriftentitel
1
Journal of clinical oncology : official journal...
1
Journal of thoracic oncology : official publica...
1
Lung cancer (Amsterdam, Netherlands)
1
The Lancet. Oncology
1
The Lancet. Respiratory medicine
Alle anzeigen ...
weniger ...
Thema
5
EC 2.7.10.1
5
Journal Article
Protein Kinase Inhibitors
Randomized Controlled Trial
4
53AH36668S
4
Anaplastic Lymphoma Kinase
4
Crizotinib
4
Research Support, Non-U.S. Gov't
3
Clinical Trial, Phase III
3
Lactams, Macrocyclic
3
OSP71S83EU
3
lorlatinib
1
5092U85G58
1
Alectinib
1
Anaplastic lymphoma kinase
1
Brigatinib
1
Carbazoles
1
EC 3.6.5.2
1
ErbB Receptors
1
HYW8DB273J
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4
2020-
1
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
5
Englisch
Haven't found what you're looking for?
Wird geladen...